Correlia Biosystems
Correlia Biosystems, based in Berkeley, CA, is a healthcare diagnostics company specializing in microscale tools for rapid biomolecule quantification, including their 'SimpleScan' technology for protein expression profiling.
Company Overview
Correlia Biosystems is a healthcare company based in Berkeley, CA, specializing in the diagnostics sub-industry. As a UC Berkeley spinoff, the company has been operational since November 2017 and was a part of Y Combinator's W18 batch. With a team size of 16, Correlia Biosystems is in the growth stage of development, expanding their innovative technologies across multiple regions including the United States, America/Canada, and offers both remote and partly remote work options.
Locations
Correlia Biosystems is headquartered in Berkeley, CA, USA. The company operates primarily within the United States and Canada but also offers remote and partly remote work arrangements. This enables them to engage a diverse talent pool and provide their services across wider geographies.
Innovative Technologies
Correlia Biosystems is at the forefront of healthcare diagnostics with its development of innovative microscale tools for the rapid quantification of biomolecules. One of their flagship offerings, the 'SimpleScan' technology, allows for dynamic monitoring of protein expression profiles. This technology supports a range of applications from next-generation proteomic data sets to point-of-care diagnostics.
Next-Gen Blood Testing
Correlia Biosystems has advanced the field of blood testing by offering next-generation solutions that provide 1000x more data to pharmaceutical companies. These innovations significantly improve the quantity and quality of data available for drug development and disease management.
Founding and Growth
Founded in November 2017, Correlia Biosystems emerged from UC Berkeley as a promising diagnostics company. The organization's inclusion in Y Combinator's W18 batch provided a crucial platform for early growth and development. Since then, Correlia Biosystems has expanded its footprint within the healthcare industry, continuing its trajectory of growth and innovation.